Brought to you by 
DexCom nets $45.6mm via FOPO
19 Mar 2009
Executive Summary
DexCom (glucose monitoring devices) netted $45.6mm through the follow-on public offering of 15.8mm common shares priced at $3.00 each. The company's CEO purchased an additional 150k shares at $3.12.
Deal Industry
- Medical Devices
-
Medical Devices
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Glucose Testing
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
DexCom nets $45.6mm via FOPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice